The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
The home New Zealand market continues to struggle, while the company was also forced to invest in added security.
Profit plunge of almost 100% in last results and flat sales market means the company’s ‘Fit for the future’ plan is at the pointy end.
An agreement has been reached with the WA government to pay 80% of repair costs for homes hit by bursting pipes made by Fletcher subsidiary Iplex.
State government expected to announce whether to accept a joint industry response to Iplex pipe issue.
Listed transport company reported a significant loss, while another turnaround strategy is actioned.
Grant Samuel report puts value of retirement village firm at between $1.63 and $1.94.
Economic headwinds don’t affect underlying foundation of Heartland, according to departing chief executive Jeff Greenslade.
But Boeing 787 deliveries are still more than a year away as airline grapples with other engine maintenance issues.
The profit fall was expected after a record 2023, and the airline says it still has work to do to rebuild its brand.